ArticleCurrent pediatrics reports2025
Metabolic Implications of PCOS.
Article in Current pediatrics reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Lipid Challenge Reveals Amplified Apolipoprotein Responses with Preserved Temporal Pattern in Polyendocrine Metabolic Ovarian Syndrome: An Exploratory Study.International journal of molecular sciences · 2026Trial
- The Limited Diagnostic Utility of Metabolic and Inflammatory Indices in Adolescent Polycystic Ovary Syndrome: A Case-Control Study.Biomedicines · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Polycystic ovary syndrome (PCOS) is a common endocrine condition among women, with associated cardiometabolic comorbidities. While there are limitations to both the diagnosis of PCOS and cardiometabolic disease within adolescence, there is evidence that adolescents with PCOS have greater risk for insulin resistance, cardiovascular and adipose tissue dysfunction, and hepatic steatosis. This review aims to explore the risk of metabolic disease in adolescents with PCOS and its association with disease phenotypes, offering insight into the evolution of this metabolic risk into adulthood. These findings reinforce the critical need for timely diagnosis of PCOS, combined with targeted lifestyle interventions, to mitigate cardiometabolic risk and shift the trajectory of long-term health outcomes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.